PAVmed Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Lishan Aklog (CEO) and Dennis M. McGrath (CFO) certified the Form 10-Q for the quarter ended June 30, 2026 on August 13, 2026. Both officers attested that the financial statements fairly present the company's condition and cash flows, disclosure controls are effective, and no material weaknesses or fraud involving management were identified in internal control over financial reporting.
Why this rating
Boilerplate SOX 302/906 certification; no specific business developments, financial numbers, or control issues disclosed.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.